Bronchial Asthma
Conditions
Brief summary
Feilike HeJi is produced by Guizhou Jianxing Pharmaceutical Co. LTD. For the treatment of phlegm heat caused by lung cough phlegm yellow, bronchial asthma, bronchitis, see the syndrome of proprietary Chinese medicine (approval number: Z20025136) approved by the state and the drug from radix scutellariae, radix peucedani, radix stemonae, red gentian root of deal, phoenix tree, spreading hedyotis herb, red tube 7 flavour, with qingrejiedu, antitussive expectorant effect. In order to fully understand the safety of Feilike HeJi in clinical practice and fulfill the responsibility of production enterprises for patients, the production enterprises initiated this study to further evaluate the safety and understanding of the function characteristics of Feilike HeJi in a wide range of people, so as to guide the clinical rational drug use.
Interventions
None listed
Sponsors
China Academy of Chinese Medical Sciences
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No
Inclusion criteria
* All minor patients (age \<18 years old) who use Feilike Mixture at the specified monitoring time and in the monitoring center (department) . * Voluntarily participate in this study and meet ethical requirements.
Exclusion criteria
* Not Applicable.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| AE | The range of adverse events was from the beginning of the use of Feilike HeJi to 3 days after the cessation of the use of Feilike HeJi. | All adverse events occurred during the study were determined according to CTCAE V5.0 for severity. |
Countries
China
Contacts
Primary ContactJing Liu, Prof
Outcome results
None listed